Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delaney, B.
Right arrow Articles by Knutson, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delaney, B.
Right arrow Articles by Knutson, N.

© 2003 The American Society for Nutritional Sciences J. Nutr. 133:468-475, February 2003


Nutrient Metabolism

ß-Glucan Fractions from Barley and Oats Are Similarly Antiatherogenic in Hypercholesterolemic Syrian Golden Hamsters1

Bryan Delaney, Robert J. Nicolosi*2, Thomas A. Wilson*, Ting Carlson{dagger}, Scott Frazer, Guo-Hua Zheng{dagger}, Richard Hess, Karen Ostergren, James Haworth and Nathan Knutson

Cargill Health and Food Technologies, Wayzata, MN 55391; * Center for Health and Disease Research, Department of Health and Clinical Sciences, University of Massachusetts-Lowell, Lowell, MA 01854; and {dagger} Cargill Sweeteners North America, Dayton, OH 45414-4321

2To whom correspondence should be addressed. E-mail: Robert_Nicolosi{at}uml.edu.

The cholesterol-lowering activities of oats and barley are commonly attributed to the ß-glucan fractions. Although ß-glucan is present in both grains and appears to be chemically similar, the effect of source on cholesterol-lowering activity has not been evaluated. In the present study, the antiatherogenic properties of ß-glucan concentrates from oats and barley were evaluated in Syrian golden F1B hamsters consuming a semipurified hypercholesterolemic diet (HCD) containing cholesterol (0.15 g/100 g), hydrogenated coconut oil (20 g/100 g) and cellulose (15 g/100 g). After a 2-wk lead-in period, control hamsters were fed the HCD, whereas experimental hamsters consumed HCD formulated to include ß-glucan (2, 4, or 8 g/100 g) by addition of ß-glucan concentrate prepared from oats or barley at the expense of cellulose. Compared with control hamsters, dose-dependent decreases that were similar in magnitude in plasma total and LDL cholesterol concentrations were observed in hamsters fed ß-glucan from either source at wk 3, 6 and 9. Compared with controls, liver cholesterol concentrations were also reduced (P < 0.05) in hamsters consuming 8 g/100 g oat or barley ß-glucan. In agreement with previously proposed mechanisms, total fecal neutral sterol concentrations were significantly increased (P < 0.05) in hamsters consuming 8 g/100 g barley or oat ß-glucan. Aortic cholesterol ester concentrations were significantly reduced (P < 0.05) in hamsters fed 8 g/100 g ß-glucan from barley or oats. Although aortic total cholesterol and cholesterol ester concentrations were significantly correlated with LDL cholesterol (r = 0.565, P < 0.004 and r = 0.706, P < 0.0001, respectively), this association could explain only half of the variability. This study demonstrated that the cholesterol-lowering potency of ß-glucan is approximately identical whether its origin was oats or barley.


KEY WORDS: • ß-glucan • LDL cholesterol • fecal neutral sterol • aortic cholesterol ester • early atherosclerosis




This article has been cited by other articles:


Home page
Crop Sci.Home page
A. Hang, D. Obert, A. I. N. Gironella, and C. S. Burton
Barley Amylose and {beta}-Glucan: Their Relationships to Protein, Agronomic Traits, and Environmental Factors
Crop Sci., July 30, 2007; 47(4): 1754 - 1760.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. W. Park, H. W. Kim, S. H. Ko, J. H. Lim, G. R. Ryu, H. W. Chung, S. W. Han, S. J. Shin, B. K. Bang, M. D. Breyer, et al.
Long-Term Treatment of Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Diabetic Nephropathy through Improving Metabolic Anomalies in db/db Mice
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1227 - 1238.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. A. Wilson, R. J. Nicolosi, B. Delaney, K. Chadwell, V. Moolchandani, T. Kotyla, S. Ponduru, G.-H. Zheng, R. Hess, N. Knutson, et al.
Reduced and High Molecular Weight Barley {beta}-Glucans Decrease Plasma Total and Non-HDL-Cholesterol in Hypercholesterolemic Syrian Golden Hamsters
J. Nutr., October 1, 2004; 134(10): 2617 - 2622.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]